PMcardio receives FDA Breakthrough Device Designation — read the full story
Powerful Medical
16. June 2023

Powerful Medical Wins the Venture Capital Deal of the Year Award!

We are thrilled to announce that Powerful Medical has been awarded the esteemed title of Venture Capital Deal of the Year at the CVCA & SLOVCA Awards competition. This recognition is a testament to our team’s dedication and the significant strides we’ve made in the past year.

Our sincere gratitude goes to our venture capital partners Venture To Future Fund, bpd partners, and CB ESPRI Impact One, whose faith in our vision and robust support has been instrumental in realising this achievement. Your investment and partnership have fueled our progress, transforming our ambitious vision into innovative solutions that became a reality.

We would also like to extend our appreciation to our esteemed partners, Kinstellar, for their invaluable legal support and Mazars for their thorough due diligence, which contributed greatly to this deal’s success.

While we are deeply honored by this award, we view it not as a final destination but as a significant milestone in our journey. This recognition reaffirms our commitment to our mission: to revolutionize cardiology with the power of AI. It fuels our determination to continue our research and development to ultimately enhance and preserve the lives of cardiac patients around the world.

As we move forward, we remain focused on our goal of expanding our impact and reach. With our incredible team, supportive partners, and a constant drive to innovate, we are excited about what the future holds for Powerful Medical. Here’s to improving lives, one heartbeat at a time. A special thank you goes to our Head of Data, Michal Martoňák, for accepting this award on behalf of the whole team!

To conclude, we would like to thank everyone who supported us along the way.

Powerful Medical

Powerful Medical leads one of the most important shifts in modern medicine by augmenting human-made clinical decisions with artificial intelligence. Our primary focus is on cardiovascular diseases, the world’s leading cause of death.
Powerful Medical leads one of the most important shifts in modern medicine by augmenting human-made clinical decisions with artificial intelligence. Our primary focus is on cardiovascular diseases, the world’s leading cause of death.
About PMcardio:

PMcardio is the market leader in AI-powered diagnostics, addressing the world’s leading cause of death – cardiovascular diseases. The innovative clinical assistant empowers healthcare professionals to detect up to 40 cardiovascular diseases. In the form of a smartphone application, the certified Class IIb medical device interprets any 12-lead ECG image in under 5 seconds to provide accurate diagnoses and individualized treatment recommendations tailored to each patient.

Share this article

Don't miss these

ECG Interpretation Tools Compared – Why PMcardio Stands Out

Interpreting ECGs accurately and swiftly is essential for clinicians at every frontline patient encounter—from primary care to emergency settings. Choosing the appropriate interpretation tool significantly impacts patient outcomes. Today, we explore three accessible solutions for clinicians: Conventional ECG Algorithms, General AI language models like ChatGPT, and PMcardio.

Powerful Medical Receives FDA Breakthrough Device Designation for PMcardio STEMI AI ECG Model

Powerful Medical, a leader in AI-driven cardiovascular diagnostics, announces that its PMcardio STEMI AI ECG model has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA). This designation recognizes PMcardio as a breakthrough technology for the detection of ST-elevation myocardial infarction (STEMI) and STEMI equivalents—a life-threatening cardiac condition requiring immediate intervention.

Join over 100,000 healthcare professionals who are already taking advantage of AI